CSRC sets forth disclosure requirements for listed pharma companies.
August 19, 2022
Corporate Governance
A U.S. company acquiring a Chinese company will face a multitude of regulatory restrictions and requirements. How can the U.S. acquirer manage the risk of the deal being blocked or unwound for non-compliance?
August 18, 2022Research casts doubt on US-listed Chinese companies' ability to list in Hong Kong; Grocery delivery company in legal trouble following collapse; new rules on convertible bonds
August 09, 2022The U.S. adds Alibaba to delisting list, citing audit non-compliance; Integration of Shenzhen and Swiss bourses; Six ESG-linked indices launched in Shenzhen
August 02, 2022Shanghai encourages pre-reorganization to avoid bankruptcies
June 30, 2022Law firms shall strengthen their management of insider information
June 24, 2022Banks and insurance companies to boost green finance development; PRC courts to develop standard uses of blockchain technology by 2025; strengthened internal management requirements ensures probity of intermediaries
June 07, 2022Potential economic downturn prompts the State Council to announce multiple significant measures aimed at supporting SMEs and foreign trade enterprises, and unlocking value in existing infrastructure projects.
June 01, 2022The head of the legal department at one of Asia's top property developers discusses the state of China's real estate sector and its likely future. Steady and environmentally sustainable growth is expected in the long term despite recent black swan events.
May 27, 2022PBOC lowers first-home buyer interest rates by 0.2%; Shenzhen establishes China's first ABS credit protection certificate; CSRC promulates prescriptive rules on public fund managers
May 24, 2022
